Market Overview

Stocks Hitting 52-Week Highs

Related MYL
Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen
Court Grants Summary Judgment In Favor Of Mylan And FDA Related To Generic
Will Congress Scuttle the AbbVie-Shire Merger? (Fox Business)

Mylan (NASDAQ: MYL) shares jumped 1.86% to create a new 52-week high of $26.35. Mylan's PEG ratio is 1.09.

Celgene (NASDAQ: CELGZ) shares gained 93.19% to touch a new 52-week high of $6.01. Celgene's pancreatic cancer drug Abraxene improved overall survival rates in a phase III study.

Gilead Sciences (NASDAQ: GILD) shares rose 12.26% to create a new 52-week high of $72.98. Gilead Sciences announced positive results in mid-stage hepatitis C virus (HCV) infection study.

Precision Castparts (NYSE: PCP) shares gained 5.64% to create a new 52-week high of $181.00. Precision Castparts (NYSE: PCP) announced its plans to acquire Titanium Metals (NYSE: TIE) for around $2.9 billion.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (GILD + CELGZ)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters